MD Anderson Cancer Center - Oncology

Houston, Texas 77030

0 studies enrolling now · 3 studies all time

What they study most

Chronic Lymphocytic Leukemia, Colorectal Cancer, Myelogenous Leukemia, Chronic, Neoplasms, Myelogenous Leukemia, Acute, Non-Hodgkins Lymphoma

Studies at this site

• Anti-CEACAM5 ADC M9140 in Advanced Solid Tumors (PROCEADE-CRC-01) — Running, not enrolling
• An Extension Study of RO5045337 in Participants Participating in Previous Roche-sponsored Cancer Studies — Completed
• A Study of Escalating Doses of Polatuzumab Vedotin in Participants With Relapsed or Refractory B-Cell Non-Hodgkins Lymphoma and Chronic Lymphocytic Leukemia and Polatuzumab Vedotin in Combination With Rituximab in Participants With Relapsed or Refractory B-Cell Non-Hodgkins Lymphoma — Completed